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1254Fractional ﬂow reserve (FFR) is
an index of the hemodynamic
signiﬁcance of a coronary ste-
nosis that is calculated directly
from measurements of hyper-
emic pressure (1,2). The physi-
ological basis of FFR has been
extensively validated in animal
and human studies, and FFR
shows good correlation to non-
invasive ischemia testing with
perfusion scintigraphy (3) and po-
sitron emission tomography (4).See page 1262FFR has been shown in 3 ran-
domized trials to identify coronary
stenoses that will beneﬁt from earlyrevascularization (those with a positive FFR) (5) and conversely
those lesions with a negative FFR for which revascularization
may be safely deferred (6,7). To measure FFR, a vasodilator
(most commonly intravenous or intracoronary adenosine) is
administered to minimize microvascular resistance and the
effect of resting hemodynamics such that coronary pressure
becomes proportional to myocardial ﬂow.
Interest has recently emerged as to whether 2 nonhyperemic
measures of pressure might be useful to assess the severity of
coronary stenosis. Pd/Pa is the ratio of distal coronary artery
pressure to aortic pressure over the entire cardiac cycle.
Conversely, the instantaneous wave-free ratio (iFR) measures
coronary pressure during a speciﬁc period of diastole when
resting resistance is the lowest (8). By reducing procedural time
and cost, avoiding patient-related discomfort from pharmaco-
logical hyperemia, and allowing continuous online mea-
surements (thereby facilitating multivessel interrogation),
assessment of the severity of coronary stenosis without induc-
tion of hyperemia is intuitively appealing, provided diagnostic
accuracy is preserved. However, in prior reports, the diag-
nostic accuracy of iFR compared with FFR has ranged
widely from 60% to 91% (8–11), and its relative accuracyology and Biomedical Engineering and Physics,
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ins the ability to distribute cost-free versions tocompared with Pd/Pa has been debated. Previous compara-
tive studies to date have been limited by different study
methodologies, modest sample sizes, and the use of different
algorithms to calculate iFR. Given these conﬂicting reports,
we formed a collaborative group of investigators to perform
a large-scale, physiology core laboratory–based analysis with
standardized methods to compare the diagnostic accuracy
of iFR and Pd/Pa with respect to FFR as the reference
standard and to determine the proportion of patients in
whom the accuracy of iFR and Pd/Pa is at least 90%.
Methods
Patient population and study inclusion criteria. The
present investigation was an international, multicenter,
nonrandomized, retrospective, core laboratory–based anal-
ysis in patients with coronary artery disease undergoing
physiological lesion assessment by FFR, iFR, and Pd/Pa. The
principal investigators representing all of the published
iFR/FFR comparative studies agreed to collaboratively par-
ticipate in this effort, including the ADVISE (ADenosine
Vasodilator Independent Stenosis Evaluation) study and
registry (8,11), VERIFY (VERiﬁcation of Instantane-
ous Wave-Free Ratio and Fractional Flow Reserve for
the Assessment of Coronary Artery Stenosis Severity in
EverydaY Practice) (9), and Johnson et al. (10). In addition,
6 other study sites contributed unpublished data to the
analysis. All studies included in this analysis were appro-
ved by the institutional review boards of the individual sites.
Original raw phasic pressure waveforms from each patient
were submitted digitally to the Physiology Core Laboratory
at the Cardiovascular Research Foundation (New York,
New York) for independent off-line analysis. In addition,
selected baseline patient demographic and procedural data
were supplied to the core laboratory. This study was an
investigator-sponsored study by theCardiovascular Research
Foundation and was supported by funding from Volcano
Corp. (San Diego, California). The funding source was
uninvolved with the design of the protocol and the analysis
and interpretation of the study results.
Patients with stable angina, unstable angina, or non–
ST-segment elevation myocardial infarction undergoingselected collaborators for research. Dr. Johnson holds a nonﬁnancial, mutual
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1255coronary angiography with or without percutaneous coro-
nary intervention in whom FFR of a single stenosis in
a major epicardial coronary artery was performed during the
procedure were considered for inclusion in the study. Two or
more lesions could be present in a single patient if in
different epicardial vessels. Exclusion criteria included left
main disease, heart failure as deﬁned by New York Heart
Association class III or IV, respiratory failure requiring
intubation or supplementary oxygen, cardiogenic shock,
signiﬁcant arrhythmia precluding waveform analysis (e.g.,
excessive premature ventricular contractions or atrial ﬁbril-
lation), and tachycardia with a heart rate >120 beats/min.
Pressure measurements and analysis. Physiological mea-
surements of coronary stenoses were performed according to
existing study protocols. The RadiAnalyzer Xpress instru-
ment with the Certus coronary pressure wire (St. Jude
Medical, Uppsala, Sweden), the Volcano s5 imaging system
with the PrimeWire (Volcano Corp., Rancho Cordova,
California), or earlier-generation equipment from these
manufacturers was used for measurements of coronary
pressure. After the pressure sensor was zeroed and equalized
to aortic pressure, it was positioned at least 5 mm distal to
the stenosis and a recording of the baseline distal coronary
and aortic pressures was obtained. After the administration
of intracoronary nitroglycerine as per the operators’ discre-
tion, hyperemia was induced by the administration of either
intravenous adenosine at a dosage of 140 mg/kg/min or
intracoronary adenosine at various doses and FFR was
calculated. All pressure tracings were submitted directly to
the Cardiovascular Research Foundation physiology core
laboratory for analysis.
FFR is the ratio of mean distal coronary pressure (Pd) to
mean aortic pressure (Pa) during maximum hyperemia. The
Pd signal is obtained from a guidewire with a piezoresistive
pressure transducer, and the Pa signal is obtained from
a ﬂuid-ﬁlled guiding or diagnostic catheter. FFR is taken as
the lowest stable value of the Pd/Pa ratio during maximal
hyperemia. To ensure accuracy of the analysis, waveform
analysis of all pressure tracings was performed to conﬁrm that
none of the following exclusion criteria were present: signif-
icant arrhythmia that may preclude appropriate waveform
analysis, loss of Pa or Pd pressure signal at any point during
the run apart from intracoronary vasodilator administration,
inappropriate recording of Pa or Pd (e.g., only a ﬂat signal is
present at some point during the recording), dampened Pa
or Pd waveform, reversed gradient during hyperemia (i.e.,
Pd pressure signal elevated above Pa, resulting in an FFR
>1.00), or sensor drift deﬁned as FFR 0.97 or 1.03 after
pullback of the pressure wire transducer into the guiding
catheter. In addition to the waveform analysis, the FFR
recording had to have an adequate baseline tracing before
administration of adenosine. Speciﬁcally, a minimum of 5
waveforms of uninterrupted recording adequate for analysis
without signiﬁcant artifact of the tracing was required. FFR
was calculated independently from the original readout as the
lowest artifact-free Pd/Pa during maximal hyperemia.iFR is the ratio of Pd/Pa measured during a pre-speciﬁed
period in mid to late diastole of the cardiac cycle without
hyperemia (8). The onset of diastole was identiﬁed from the
dicrotic notch, and the diastolic window was calculated
beginning 25% into diastole and ending 5 ms before end
diastole. iFR was calculated off-line in the core laboratory
using the Volcano Harvest software package, which contains
the iFR computational algorithm developed at the Imperial
College of London (8). All analyses were performed in
a fully automated manner, eliminating the need for manual
selection of data time points. This automated analysis is
based on a synchronized electrocardiographic (ECG) signal
to determine the appropriate diastolic intervals for pressure
measurements. If the ECG signal was missing, the core
laboratory manually inserted R-wave markings based on the
pressure waveform into the baseline tracing from which iFR
was calculated.
Resting Pd/Pa was calculated in similar fashion to iFR
except that Pd/Pa was time averaged over the entire cardiac
cycle, thus including both systole and diastole. In addition
to the exclusion criteria for measurement of FFR, iFR
and Pd/Pa recordings with any of the following character-
istics were excluded from the analysis: insufﬁcient baseline
recording before administration of adenosine (recording had
to contain at least 5 cardiac cycles from the start of the
recording to the onset of hyperemia), signiﬁcant arrhythmias
including supraventricular tachycardia or premature ventri-
cular contractions within the baseline tracing, or heart rate
<50 or >120 beats/min.
Core laboratory analyses were performed in a blinded
fashion at 3 separate workstations by different technicians in
sequential, independent phases. First, a thorough waveform
analysis was performed of all baseline and hyperemic trac-
ings, and pressure recordings meeting any of the previously
outlined exclusion criteria were removed from the analysis.
Second, an independent calculation of FFR was performed
blinded to the original FFR readout. Third, fully auto-
mated, computerized calculations of Pd/Pa and iFR were
performed by a physician unaware of the waveform analysis
and computation of FFR. All tracings were over-read by
a physician experienced in physiology measurements (A.M.,
P.G., or A.J.) to ensure data quality. FFR, iFR and Pd/Pa
data were recorded on separate case report forms that were
not merged until the completion of the blinded analyses.
Study endpoints. The primary objective of this study was
to evaluate the level of diagnostic accuracy of iFR and Pd/Pa
compared with FFR in a variety of clinical settings in the
largest population studied to date using rigorous, pre-
speciﬁed core laboratory–based processes. Using FFR as
the reference standard, the primary endpoint of the study
was to identify the iFR thresholds that most strongly cor-
related with an FFR cut point of 0.80 and to determine the
proportion of lesions for which these thresholds applied.
Thresholds with 90% diagnostic accuracy were calcula-
ted (pre-speciﬁed as representing the minimal thresholds
required for the potential clinical utility of iFR), and the
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1256proportions of lesions that fell beyond those thresholds were
determined (deﬁned as the adenosine-free zone).
Secondary study objectives included determining the
iFR thresholds necessary to achieve >90% to 99% diag-
nostic accuracy, construction of receiver-operating charac-
teristic (ROC) curves for iFR to assess the optimal cutoff
point with respect to the clinical threshold of FFR 0.80,
assessment of the overall correlation between iFR and FFR
using regression techniques, and assessment of the sensi-
tivity, speciﬁcity, positive predictive value (PPV), negative
predictive value (NPV), and overall diagnostic accuracy at
that cutoff point. All of the preceding analyses were also
performed with the cycle-averaged resting pressure ratio
Pd/Pa, and iFR and Pd/Pa were directly compared with
respect to their diagnostic accuracy. In addition, subgroup
analyses were performed for both iFR and Pd/Pa with respect
to coronary vessel (left anterior descending [LAD] coronary
artery vs. non-LAD), route of adenosine administration
(intravenous vs. intracoronary), and study site (to assess
center variability).
Statistical analysis. Data are summarized by descriptive
statistics. Pearson’s correlation and linear regression anal-
ysis were performed to examine the relationship between
iFR and FFR and Pd/Pa and FFR, respectively. ROC
curves were constructed to identify the concordance bet-
ween FFR, iFR, and Pd/Pa. Agreement between the
methods was assessed by Bland-Altman plots with corre-
sponding 95% limits of agreement. Sensitivity, speciﬁcity,
PPV, NPV, and overall diagnostic accuracy of measure-
ment of iFR and Pd/Pa relative to an FFR cutoff of 0.80
were determined, C statistics were generated, and optimal
cutoff values for iFR and Pd/Pa were computed based on
maximizing the sum of sensitivity plus speciﬁcity. Binary
variables were compared using chi-square testing. From
the raw data examining the relationship between iFR
(or Pd/Pa) and FFR, separate iFR (Pd/Pa) thresholds were
determined for which the PPV and NPV were each 90%
(corresponding to an FFR of0.80 and>0.80, respectively),
and the proportion of lesions meeting these criteria was
determined. Similar analyses were performed using different
thresholds from 90% to 99%. SAS software version 9.1
(SAS Institute, Cary, North Carolina) was used for all
analyses, and a 2-tailed p value of <0.05 was regarded as
statistically signiﬁcant.Figure 1
Scatter Plot Showing the Relationship Between
iFR and FFR and Pd/Pa and FFR
The dashed blue line represents the line of best ﬁt. (A) The horizontal dashed line
notes the optimal iFR cutoff of 0.90 on the basis of ROC analysis. (B) The
horizontal dashed line notes the optimal Pd/Pa cutoff of 0.92. FFR¼ fractional ﬂow
reserve; iFR ¼ instantaneous wave-free ratio; Pd/Pa ¼ distal coronary artery
pressure/aortic pressure; ROC ¼ receiver-operating characteristic.Results
Patient demographics and procedural data. A total of
1,768 patients with 1,974 lesions from 15 clinical sites were
submitted for analysis. Of these lesions, 381 (19.3%) met at
least one of the pre-deﬁned core laboratory exclusion criteria,
leaving 1,593 lesions for ﬁnal analysis. The most common
reasons for exclusion were insufﬁcient baseline recording or
artifact during recording (n ¼ 227), lesions not meeting
study entry criteria (n ¼ 56), pressure drift or incorrect
calibration (n ¼ 42), and other technical factors (n ¼ 56).The mean age of the population was 63.4  10.3 years,
and 74.9% were male. A total of 21.2% had prior myocar-
dial infarction and 28.1% had diabetes mellitus, and 29.4%
were current smokers. A small fraction had prior coronary
artery bypass grafting (3.4%), chronic kidney disease (8.3%),
and congestive heart failure (6.3%). The clinical presentation
was most commonly chronic stable angina (68.6%), with
14.4% having unstable angina and 8.4% non–ST-segment
elevation myocardial infarction. More than half of the
population had multivessel coronary artery disease (53.8%);
the LAD coronary artery was the most commonly interro-
gated target lesion (63%), followed by the right coronary
artery (20%) and the left circumﬂex artery (17%). FFR
studies were performed with intravenous adenosine in 80.1%
of cases and intracoronary adenosine in the remainder.
Relationships between FFR, iFR, and Pd/Pa. The
median (interquartile range) FFR, iFR, and Pd/Pa in this
study population was 0.79 (0.70 to 0.86), 0.90 (0.83 to
Figure 3 Bland-Altman Analysis
Bland-Altman plots of differences against the means are displayed for (A) iFR and
(B) Pd/Pa. The zero line is displayed in red. The mean bias is represented by the
solid blue line (with the 95% conﬁdence interval represented by the dashed blue
line). Abbreviations as in Figure 1.
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12570.95), and 0.93 (0.86 to 0.96), respectively. A scatter plot
between iFR and FFR is shown in Figure 1A, demon-
strating moderate overall linear correlation between the 2
measures, with an R2 of 0.66 (95% conﬁdence interval [CI]:
0.64 to 0.70) (p < 0.001). Similarly, the correlation of
resting Pd/Pa and FFR demonstrated an R
2 of 0.69 (95%
CI: 0.67 to 0.72) (p < 0.001) (Fig. 1B). Although the
overall correlations between Pd/Pa versus FFR and iFR
versus FFR were similar, the data points were more clustered
around the regression line with a ﬂatter slope and greater
intercept for the Pd/Pa versus FFR relationship. The area
under the ROC curve (C statistic) to predict an FFR 0.80
was 0.81 (95% CI: 0.79 to 0.83) for iFR and 0.82 (95% CI:
0.80 to 0.84) for Pd/Pa, indicating moderate to good
discrimination for both (Fig. 2). The optimal cutoff value for
an FFR 0.80 derived from ROC analyses was 0.90 for iFR
and 0.92 for Pd/Pa.
Bland-Altman plots for iFR and Pd/Pa are shown in
Figures 3A and 3B, respectively. On average, iFR exceeded
FFR by þ0.10 (95% CI: 0.06 to þ0.26) and Pd/Pa
exceeded FFR by þ0.14 (0.01 to þ0.29). However, both
iFR and Pd/Pa demonstrated a substantial degree of scatter,
particularly below the threshold of 0.80.
The correlation between iFR and Pd/Pa is shown in
Figure 4A. There was a strong correlation between these 2
parameters (R2 ¼ 0.95; p < 0.001), showing that 95% of the
variation in iFR was accounted for by Pd/Pa. However,
Bland-Altman analysis showed that Pd/Pa overestimates iFR
on average by 0.04 and substantially more when the iFR
is <0.80 (Fig. 4B).
Diagnostic accuracy of iFR. The overall sensitivity,
speciﬁcity, PPV, and NPV for iFR 0.90 versus FFR
0.80 was 78.9%, 82.4%, 85.2%, and 73.3%, respectively,
with an overall diagnostic accuracy of 80.4%. To achieve
90% diagnostic accuracy at each extreme, the overallFigure 2 ROC Curves for iFR and Pd/Pa
Comparisons are made with an FFR at a cut point of 0.80. Abbreviations as
in Figure 1.iFR range had to be restricted to 0.88 (to predict an
FFR 0.80) and 0.97 (to predict an FFR >0.80),
comprising 1,034 of the 1,593 study lesions (64.9%). In
other words, if a 90% diagnostic accuracy compared with
FFR is deemed sufﬁcient for therapeutic interchangeability,
64.9% (95% CI: 62.6% to 67.3%) of the study lesions
would fall within the adenosine-free zone and not require
hyperemia for the diagnosis of ischemia. Figure 5 demon-
strates the association between the adenosine-free zone
and diagnostic accuracy. The adenosine-free zone narrows
as increasing diagnostic accuracy of iFR is required, such
that only 28.6% (26.4% to 30.8%) and 18.0% (16.1% to
19.8%) of lesions would achieve 95% and 99% diag-
nostic accuracy, respectively.
Diagnostic accuracy of Pd/Pa. The sensitivity, speciﬁcity,
PPV, and NPV for a Pd/Pa 0.92 for an FFR 0.80 was
76.3%, 88.1%, 89.2%, and 74.4%, respectively, resulting in
an overall diagnostic accuracy of 81.5%. A diagnostic
accuracy of 90% was achieved when the Pd/Pa range was
restricted to 0.92, with 769 of the 1,593 (48.3%; 45.6%
to 50.5%) lesions falling in that range. However, in
contrast to iFR, there was no upper boundary of Pd/Pa that
predicted with 90% accuracy a negative FFR value (i.e.,
Figure 4 Relationship Between iFR and Pd/Pa
(A) The scatter plot demonstrates a highly linear relationship. (B) The Bland-
Altman plot displays differences against the mean, demonstrating substantial
variation between iFR and Pd/Pa. Abbreviations as in Figure 1. Lines as in Figure 3.
Figure 5
Association Between Use of Adenosine and
Diagnostic Accuracy of iFR and Pd/Pa
An inverse relationship between use of adenosine and diagnostic accuracy is
shown, such that with increasing accuracy the adenosine-free zone decreases in
width for both iFR and Pd/Pa. The blue line displays this association for iFR and the
red line for Pd/Pa. Abbreviations as in Figure 1.
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1258>10% of lesions with a Pd/Pa of 1.00 had an FFR 0.80).
Figure 5 shows the association between the adenosine-free
zone and diagnostic accuracy for Pd/Pa. Similar to iFR,
there was a trade-off between diagnostic accuracy and the
size of the adenosine-free zone. Only 36.0% (33.7% to
38.4%) and 19.5% (17.5% to 21.4%) of lesions would
achieve a diagnostic accuracy of 95% and 99%,
respectively.
Subgroup analyses. There was no signiﬁcant difference in
the diagnostic accuracy of iFR compared with FFR with
intravenous versus intracoronary administration of adenosine
(81.5% vs. 78.2%; p ¼ 0.07) or among patients presenting
with stable versus unstable angina (80.4% vs. 80.2%;
p ¼ 0.97). Similarly, no signiﬁcant differences in diagnostic
accuracy were noted when LAD coronary artery stenoses
were compared with non-LAD coronary artery stenoses
(79.9% vs. 81.9%; p ¼ 0.34) or for tracings with versus
without an embedded ECG signal (83.7% vs. 80.2%;
p ¼ 0.39). Finally, the variation in overall accuracy between
iFR and FFR at individual study sites ranged from 78.6%
to 82.7%, and the correlation varied from an R2 of 0.54 to
an R2 of 0.72 (Table 1). For Pd/Pa, the overall accuracyranged from 72.6% to 89.5% and the correlation varied
from an R2 of 0.61 to an R2 of 0.75.
Discussion
In this large, core laboratory–based analysis, the overall
linear correlation between both iFR and Pd/Pa and FFR was
moderate (R2 ¼ 0.66 and 0.69, respectively), with an overall
diagnostic accuracy ofw80% for both nonhyperemic indices
(using the optimal ROC-determined cutoff points of 0.90
and 0.92 to predict an FFR 0.80). The diagnostic accuracy
was independent of vessel, embedded versus core laboratory–
generated ECG gating signal, use of intravenous versus
intracoronary adenosine to induce hyperemia, and clinical
site. Accepting FFR as the reference method (in the absence
of outcome studies with iFR or Pd/Pa), this level of accuracy
is insufﬁcient to use either parameter for procedural guid-
ance in all cases because w20% of therapeutic decisions
would be discordant from FFR.
Although iFR and Pd/Pa are imperfect surrogates of
FFR close to the clinically used cutoff value of 0.80
(11), they may still provide acceptable accuracy at greater
or lesser degrees of functional stenosis severity. The
fundamental principle of FFR, justifying pressure-derived
estimation of coronary ﬂow impairment, is that the trans-
lesional pressure ratio approximates ﬂow when microvas-
cular resistance is minimized (12,13), requiring the use of
a potent vasodilator. However, microvascular resistance is
inﬂuenced by many factors, including capacitive, inertial,
and resistive forces as well as the complex effects of systolic
contraction. Nonhyperemic pressure ratios may theoreti-
cally have adequate concordance with hyperemic pressure
measurements when there is a large baseline gradient (i.e.,
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1259obvious impairment of coronary ﬂow) or no gradient at
all (i.e., absence of any resting ﬂow disturbance). In this
regard, a recent retrospective analysis of almost 500
patients demonstrated a good correlation between Pd/Pa
and FFR with an area under the curve of 0.86 (14). When
only translesional resting pressure ratios of <0.88 and
>0.95 were considered, the PPV and NPV increased to
>95%, with more than half of the study population falling
in these categories. The present larger, multicenter, core
laboratory–based analysis shows that if 90% accuracy com-
pared with the FFR reference standard is accepted at the
margins (the pre-speciﬁed precision limit for therapeutic
interchangeability in the present study), use of iFR and
Pd/Pa might avoid hyperemia in 65% and 48% of lesions,
respectively. If 95% accuracy is required, however, use of
iFR and Pd/Pa might avoid hyperemia in only 29% and
36% of lesions, respectively. In addition, the percentage of
lesions falling into the adenosine-free zone will vary
based on the spectrum of lesions being studied. If only
intermediate lesions are investigated (i.e., with an FFR near
0.80 in a greater proportion of patients), the adenosine-free
zone may be smaller compared with the ﬁndings of the
current study.
A secondary goal of the present study was to compare and
contrast iFR and Pd/Pa. By restricting measurements to
a speciﬁc segment of diastole in which the maximum
achievable coronary ﬂow occurs during resting conditions,
iFR has a theoretical advantage compared with Pd/Pa.
However, using FFR as the reference standard, we found no
signiﬁcant differences between iFR and Pd/Pa with respect
to sensitivity, speciﬁcity, PPV, NPV, or diagnostic accuracy.
Although modest differences were noted between the iFR
and Pd/Pa versus FFR regression patterns, the overall similar
results are consistent with a prior retrospective analysis by
Johnson et al. (10). Prospective studies are required to
determine whether the differences between iFR and Pd/Pa
are practically or clinically relevant.
Study limitations. The present study has several strengths
but also some limitations. Prior studies examining the
relationship between iFR, Pd/Pa, and FFR showed signi-
ﬁcant variability and thus reached strikingly different
conclusions (8–10). In this regard, it is reassuring to note
that by applying a rigorous study methodology, common
inclusion and exclusion criteria, and a standardized physi-
ology assessment methodology, the data from these prior
studies showed relatively little variation, with diagnostic
accuracy ranging from 79% to 83%. We have applied linear
models to our data, although the complete physiological
relationship between FFR and iFR or rest Pd/Pa may best
be described by a curvilinear relationship. RESOLVE is
the ﬁrst coronary physiology study that used a core labo-
ratory for analysis of hyperemic and resting pressure–
derived indices of the severity of stenosis. Surprisingly, 19%
of measurements were found to be suboptimal and were
excluded from the analysis (perhaps explaining the reduced
site-to-site variability in the present report compared with
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1260previously reported individual studies). Future clinical trials
should consider including core laboratory analysis to assess
the validity of hemodynamic measurements, as is currently
the standard for quantitative coronary angiography and
intravascular ultrasonography. An additional strength is the
size of the present study, encompassing all iFR studies
published to date as well as several nonpublished clinical
experiences, which provides incremental power to accu-
rately locate point estimates while reducing CI width and
affording subgroup analysis. However, the present retro-
spective analysis is limited by nonuniform patient and
lesion characteristics at each site and varying FFR acqui-
sition protocols. Despite the fact that all studies underwent
rigorous analysis by an independent core laboratory to
eliminate potential erroneous measurements and minimize
variability, we cannot fully exclude selection bias and other
sources of inconsistencies. A ﬁnal pullback of the pressure
wire into the guiding catheter conﬁrming the absence of
pressure drift was not required and was performed in only
a small minority of cases.
Clinical implications. As with any diagnostic test FFR,
iFR and Pd/Pa have inherent variability (9,15,16). On the
basis of 3 randomized trials showing superior clinical
outcomes with FFR guidance compared with angiographic
guidance alone (5–7), FFR is justiﬁably accepted as the
standard in both US and European guidelines for invasive
physiological lesion assessment and clinical decision making
(17,18). On the basis of the present report and consistent
with prior studies (9,10), the universal adoption of iFR or
Pd/Pa with use of a single cutoff point cannot be recom-
mended (19). However, using a hybrid approach wherein
Pd/Pa or iFR are accepted at the 2 outer tails of the spectrum
with FFR-based decisions required in the gray area in
between (20) may be feasible and might avoid the use
of hyperemia in approximately 48% to 65% of lesions,
respectively, if 90% correlation with an FFR cutoff 0.80
is accepted. Although there will always be a trade-off for
greater diagnostic accuracy (e.g., if >99% accuracy compared
with FFR is desired, the adenosine-free zone would shrink
to <20% of patients), a small (10%) degree in variability
between nonhyperemic physiological measurements and
FFR in a large proportion of patients may be acceptable to
many physicians in daily clinical practice given the cost,
inconvenience, and potential side effects associated with
administration of adenosine (21,22) and the relatively low
major adverse cardiac event rate around the FFR 0.80 cut
point (5), where most classiﬁcation errors are likely to occur.
However, the iFR and Pd/Pa cutoff values identiﬁed in the
present retrospective study require validation, and prospec-
tive randomized trials are required to determine whether
a hybrid strategy results in noninferior clinical outcomes to
the routine use of FFR.
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